Normal view MARC view ISBD view

How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation?

Knechtle, Stuart J

How does alemtuzumab affect long-term graft and patient outcomes after deceased-donor kidney transplantation? [electronic resource] - Nature clinical practice. Nephrology Dec 2005 - 74-5 p. digital

Publication Type: Journal Article

ISSN: 1745-8323

Standard No.: 10.1038/ncpneph0052 doi

Subjects--Topical Terms:
Alemtuzumab
Antibodies, Monoclonal--therapeutic use
Antibodies, Monoclonal, Humanized
Antibodies, Neoplasm--therapeutic use
Cadaver
Graft Survival
Humans
Immunosuppressive Agents--therapeutic use
Kidney Transplantation
Time Factors

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)